# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Benny Leonard (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX008-SYN-TD
- Date: 1946-07-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Miriam Okafor-Rosenthal, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with a problem-oriented visit (CPT 99213, modifier 25) for the recheck and medication change

## Chief complaint

Periodic adult preventive visit, and the recheck after last week's sick visit. **S**

## History of present illness

Mr. Leonard, 50, comes for his yearly preventive visit, which also serves as the recheck one week after the sick visit. He drank as advised, the lightheadedness went within a day, his urine is pale and the cramps have stopped. He has not taken losartan-hydrochlorothiazide for a week, and his home readings have risen to about 142/88 mmHg. He has not refereed this week. He takes atorvastatin each evening without muscle aches. He wants to be back in the ring next week, and asks whether there is a blood pressure medicine that will not dry him out in the heat. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 50, with a recheck after volume depletion |
| Blood pressure | 142/88 mmHg in the clinic; home about 142/88 mmHg off treatment for a week |
| Kidney function | Creatinine 1.04 mg/dL, potassium 4.1 mmol/L, recovered |
| Cholesterol | LDL 66 mg/dL nine weeks after starting atorvastatin, from 160 |
| Mood | PHQ-2 1 |

## Health risk assessment

Written questionnaire completed by the patient in the waiting room and reviewed with him by Dr. Okafor-Rosenthal. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good; better since his blood pressure was treated, apart from last week |
| Psychosocial | Many friends in boxing; worries about money less now that he is working full cards again |
| Tobacco | Never |
| Alcohol and drugs | A glass of wine on the Sabbath and holidays; AUDIT-C 2 at intake; no drugs |
| Physical activity | Walks to work and moves throughout fight nights; has started a brisk walk most mornings |
| Nutrition | Fewer deli meats and pickles; more fruit, vegetables and fish; eats earlier before fights |
| Sleep | Six to seven hours; late nights after fights |
| Driving and injury | Rides the subway or takes taxis; seat belt in cars |
| Home safety | Smoke alarm working; no firearms |
| Financial strain | Pays for his medicines; generic once-daily tablets are affordable; no food or housing insecurity |
| Dental | Dentist once a year |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss or fatigue now |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Hears well; no mouth problems |
| Cardiovascular | Negative | No chest discomfort, lightheadedness, palpitations or ankle swelling |
| Respiratory | Negative | No breathlessness or cough |
| Gastrointestinal | Negative | No change in bowel habit or blood in the stool |
| Genitourinary | Negative | Urine pale; no urinary symptoms |
| Musculoskeletal | Negative | No muscle aches on atorvastatin; cramps gone |
| Integumentary | Negative | No new or changing skin spots |
| Neurological | Negative | No headache, weakness or numbness |
| Psychiatric | Negative | Mood good; PHQ-2 1 |

11 systems reviewed. **S**

## Current medications

- Atorvastatin 40 mg tablet, one each evening **S**
- Losartan 100 mg tablet, one each morning **S**
- Amlodipine 5 mg tablet, one each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 142/88 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 73.6 kg; BMI 27 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.1 mmol/L; Urea nitrogen: 17 mg/dL; Creatinine: 1.04 mg/dL; eGFR: 86 mL/min/1.73 m²; Glucose: 95 mg/dL; Total cholesterol: 138 mg/dL; HDL cholesterol: 47 mg/dL; LDL cholesterol (calculated): 66 mg/dL; Triglycerides: 124 mg/dL; PHQ-2: 1. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 4.1 mmol/L at baseline, 4.1 mmol/L at this visit **S**
- Urea nitrogen: 15 mg/dL at baseline, 17 mg/dL at this visit **S**
- Creatinine: 0.98 mg/dL at baseline, 1.04 mg/dL at this visit **S**
- eGFR: 93 mL/min/1.73 m² at baseline, 86 mL/min/1.73 m² at this visit **S**
- Glucose: 96 mg/dL at baseline, 95 mg/dL at this visit **S**
- Total cholesterol: 234 mg/dL (high) at baseline, 138 mg/dL at this visit **S**
- HDL cholesterol: 44 mg/dL at baseline, 47 mg/dL at this visit **S**
- LDL cholesterol (calculated): 160 mg/dL (high) at baseline, 66 mg/dL at this visit **S**
- Triglycerides: 150 mg/dL (high) at baseline, 124 mg/dL at this visit **S**

## Immunizations given today

- Pneumococcal conjugate vaccine PCV20, single dose, recommended for all adults 50 and older **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 73.6 kg, BMI 27.0; blood pressure 142/88 mmHg; pulse 72; no orthostatic fall |
| Eyes | Fundi with mild arteriolar narrowing; no hemorrhages or exudates |
| Cardiovascular | Regular rhythm; fourth heart sound; no murmur; no carotid bruit; foot pulses normal; no edema |
| Respiratory | Clear |
| Abdomen | Soft; no aortic pulsation felt |
| Skin | No lesions of concern |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. Colorectal cancer screening is due at 50 and he chose a stool test (FIT). HIV, hepatitis C and hepatitis B screening drawn today. **S**
   - PCV20 and the first recombinant zoster dose today; second zoster dose in two to six months.
   - FIT kit given, to return by mail.
   - Hepatitis B vaccine after the screening result if he is not immune.
   - Influenza and this season's COVID-19 vaccine in the autumn.
   - Next preventive visit in one year.
2. **Volume depletion** (E86.0). Resolved: creatinine 1.04 mg/dL and potassium 4.1 mmol/L, with no orthostatic fall. **S**
   - Keep drinking water between bouts on fight nights.
3. **Hypertensive heart disease** (I11.9). Off treatment for a week his blood pressure is back to 142/88 mmHg. A thiazide is a poor fit for a man who loses a great deal of salt and water in hot arenas, so he changes to losartan with amlodipine, the alternative Dr. Achebe-Lindqvist suggested, rather than restarting the combination. **S**
   - Losartan 100 mg and amlodipine 5 mg each morning from today; losartan-hydrochlorothiazide stopped.
   - Basic metabolic panel in four weeks, at the fifteen-week visit.
   - Written sick-day rules for his wallet: on a day of vomiting, diarrhea or heavy sweating without drinking, skip losartan and call.
   - Back to refereeing next week, with water between bouts.
4. **Coronary atherosclerosis (calcium score 186)** (I25.10). LDL 66 mg/dL, 59% below intake, on atorvastatin 40 mg without side effects: at goal. **S**
   - Continue atorvastatin 40 mg; lipid panel in a year.

## Medication changes

- Stopped: Losartan 100 mg with hydrochlorothiazide 25 mg, one tablet each morning **S**
- Started: Losartan 100 mg tablet, one each morning **S**
- Started: Amlodipine 5 mg tablet, one each morning **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 142/88 mmHg after a week off treatment; regimen changed |
| Lipids and statin | Completed today | LDL 66 mg/dL on atorvastatin 40 mg, from 160 |
| Prediabetes and type 2 diabetes screening | Up to date | HbA1c 5.5% at intake |
| Colorectal cancer screening | Ordered | Due from 45; he chose a yearly FIT; kit given today |
| Prostate cancer screening | Not indicated | PSA screening is an individual decision from 55 to 69; he is 50 with no known higher risk |
| Lung cancer screening | Not indicated | Never smoked |
| HIV screening | Completed today | Routine one-time screening for ages 15 to 65 |
| Hepatitis C screening | Completed today | One-time screening for all adults |
| Hepatitis B screening | Completed today | Triple panel, once for all adults |
| Depression screening | Completed today | PHQ-2 1; PHQ-9 5 at intake |
| Anxiety screening | Up to date | GAD-7 6 at intake, mild; repeat at six months |
| Unhealthy alcohol use | Up to date | AUDIT-C 2 at intake |
| Pneumococcal vaccine | Completed today | PCV20 today; no further dose needed |
| Zoster vaccine | Completed today | First recombinant dose today; second in two to six months |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap five years ago |
| Hepatitis B vaccine | Due | Recommended for all adults 19 to 59; given after the screening result if he is not immune |
| Influenza vaccine | Due | When this season's vaccine arrives in the autumn |
| COVID-19 vaccine | Due | In the autumn after discussion |

## Advance care planning

Voluntary discussion of about 15 minutes, with his consent. He named a health care agent, recorded in the chart and not named here, and completed a health care proxy form. He said he would want resuscitation and full treatment for any illness from which he could recover, and asked that his religious traditions be respected in hospital. The plan will be revisited every few years or after any serious illness. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026), American College of Cardiology and American Heart Association (Circulation 2026;153(17):e1154-e1276)
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Fifteen-week review in four weeks with a basic metabolic panel. FIT kit by mail. Screening results by phone. Second zoster dose in two to six months; influenza and COVID-19 vaccines in the autumn. Next preventive visit in one year. **S**
- Next scheduled visit 1946-08-25: fifteen-week review: blood pressure after the change of medicine, kidney function and potassium, cholesterol on the statin, and the sick visit. **S**
